Chemours CompanyNYSE: CC

The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

· Published via Business Wire

Summary by 6ix AI

Law firm Kahn Swick & Foti, LLC (KSF) reminded investors with substantial losses who bought The Chemours Company securities between February 20, 2026 and August 4, 2026, inclusive, that they have until December 7, 2026 to apply to lead a securities class action against Chemours in the United States District Court for the District of Delaware.

Key details

  • The lawsuit charges Chemours and certain of its executives with failing to disclose material information during that period, in violation of federal securities laws.
  • On August 4, 2026, after the market closed, Chemours reported second-quarter 2026 results and cut its full-year adjusted EBITDA (a measure of operating earnings) guidance to $775–$825 million, down from $800–$900 million. On this news, its shares fell $3.34, or 18.63%, to close at $14.59 per share on August 5, 2026.
  • On the earnings call the next morning, CEO Denise Dignam said that "[a]s a result of the initial channel fill, aftermarket customers built additional inventory, creating an oversupplied channel heading into 2026."
  • On the same call, CFO Shane Hostetter said that, "from the Q2 and Q3 perspective, there's probably about $65 million of aftermarket sales that . . . probably should have been allocated to more of this year."
  • The case is Darcy v. The Chemours Company, et al., No. 26-cv-01299.

What’s still pending

  • The case is pending, and the claims against Chemours and its executives are charges made in the lawsuit.
  • Investors who wish to serve as lead plaintiff must petition the court by December 7, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC), if they purchased or otherwise acquired the Company’s securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.

What You May Do

If you purchased securities of Chemours as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3615 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-cc/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by December 7, 2026.

>>>CLICK HERE for more information

About the Lawsuit

Chemours and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On August 4, 2026, post-market, the Company announced its 2Q 2026 financial results and cut its full-year adjusted EBITDA guidance to $775–$825 million, down from $800–$900 million. On the earnings call the next morning, CEO Denise Dignam admitted that “[a]s a result of the initial channel fill, aftermarket customers built additional inventory, creating an oversupplied channel heading into 2026.” CFO Shane Hostetter added that, “from the Q2 and Q3 perspective, there’s probably about $65 million of aftermarket sales that . . . probably should have been allocated to more of this year.”

On this news, the price of Chemours’ shares fell $3.34 per share, or 18.63%, to close at $14.59 per share on August 5, 2026.

The case is Darcy v. The Chemours Company, et al., No. 26-cv-01299.

>>>To Learn More, Click HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click HERE

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

View original source (Business Wire)Chemours Company on 6ix

Earlier from Chemours

All Chemours news releases